623 related articles for article (PubMed ID: 25826665)
1. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
[TBL] [Abstract][Full Text] [Related]
2. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17.
Jiang Z; Cote J; Kwon JM; Goate AM; Wu JY
Mol Cell Biol; 2000 Jun; 20(11):4036-48. PubMed ID: 10805746
[TBL] [Abstract][Full Text] [Related]
3. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
[TBL] [Abstract][Full Text] [Related]
4. tau Exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5' and 3' splice sites.
D'Souza I; Schellenberg GD
J Biol Chem; 2002 Jul; 277(29):26587-99. PubMed ID: 12000767
[TBL] [Abstract][Full Text] [Related]
5. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
Kalbfuss B; Mabon SA; Misteli T
J Biol Chem; 2001 Nov; 276(46):42986-93. PubMed ID: 11560926
[TBL] [Abstract][Full Text] [Related]
6. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17.
Varani L; Hasegawa M; Spillantini MG; Smith MJ; Murrell JR; Ghetti B; Klug A; Goedert M; Varani G
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8229-34. PubMed ID: 10393977
[TBL] [Abstract][Full Text] [Related]
7. A Disease-Causing Intronic Point Mutation C19G Alters Tau Exon 10 Splicing via RNA Secondary Structure Rearrangement.
Tan J; Yang L; Ong AAL; Shi J; Zhong Z; Lye ML; Liu S; Lisowiec-Wachnicka J; Kierzek R; Roca X; Chen G
Biochemistry; 2019 Mar; 58(12):1565-1578. PubMed ID: 30793898
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.
Rodriguez-Martin T; Garcia-Blanco MA; Mansfield SG; Grover AC; Hutton M; Yu Q; Zhou J; Anderton BH; Gallo JM
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15659-64. PubMed ID: 16230627
[TBL] [Abstract][Full Text] [Related]
9. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
10. Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.
Rodriguez-Martin T; Anthony K; Garcia-Blanco MA; Mansfield SG; Anderton BH; Gallo JM
Hum Mol Genet; 2009 Sep; 18(17):3266-73. PubMed ID: 19498037
[TBL] [Abstract][Full Text] [Related]
11. Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing.
Peacey E; Rodriguez L; Liu Y; Wolfe MS
Nucleic Acids Res; 2012 Oct; 40(19):9836-49. PubMed ID: 22844088
[TBL] [Abstract][Full Text] [Related]
12. RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing.
Ong AAL; Tan J; Bhadra M; Dezanet C; Patil KM; Chong MS; Kierzek R; Decout JL; Roca X; Chen G
Molecules; 2019 Aug; 24(16):. PubMed ID: 31434312
[TBL] [Abstract][Full Text] [Related]
13. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta.
Jiang Z; Tang H; Havlioglu N; Zhang X; Stamm S; Yan R; Wu JY
J Biol Chem; 2003 May; 278(21):18997-9007. PubMed ID: 12649279
[TBL] [Abstract][Full Text] [Related]
14. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
15. Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion.
D'Souza I; Schellenberg GD
J Biol Chem; 2000 Jun; 275(23):17700-9. PubMed ID: 10748133
[TBL] [Abstract][Full Text] [Related]
16. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
Wang Y; Wang J; Gao L; Stamm S; Andreadis A
Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
[TBL] [Abstract][Full Text] [Related]
17. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10.
Hasegawa M; Smith MJ; Iijima M; Tabira T; Goedert M
FEBS Lett; 1999 Jan; 443(2):93-6. PubMed ID: 9989582
[TBL] [Abstract][Full Text] [Related]
18. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
Yu Q; Guo J; Zhou J
J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
[TBL] [Abstract][Full Text] [Related]
19. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.
D'Souza I; Poorkaj P; Hong M; Nochlin D; Lee VM; Bird TD; Schellenberg GD
Proc Natl Acad Sci U S A; 1999 May; 96(10):5598-603. PubMed ID: 10318930
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and Regulation of Alternative Pre-mRNA Splicing.
Lee Y; Rio DC
Annu Rev Biochem; 2015; 84():291-323. PubMed ID: 25784052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
